XML 34 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHAREHOLDERS' EQUITY (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 29, 2012
USD ($)
Mar. 31, 2012
USD ($)
Jun. 30, 2012
USD ($)
Jun. 30, 2011
USD ($)
Jul. 19, 2012
Jun. 30, 2012
ILS
Dec. 31, 2011
Dec. 31, 2011
ILS
SHAREHOLDERS' EQUITY [Abstract]                
Reverse stock split ratio         4      
Reverse stock split, nominal value per share           0.1    
Reverse stock split, nominal value per share after split           0.4   0.4
Convertible Notes, amount converted $ 230,000 $ 467            
Convertible notes, shares issued 92,742 223,750            
Bifurcated conversion feature allocated to equity 550,000 162            
Convertible debt inducement expenses     108,000           
Additional shares issued 39,407 56,541            
Conversion price $ 0.48 $ 0.48            
Weighted average assumptions:                
Risk free interest     1.00% 1.87%        
Dividend yields     0.00% 0.00%        
Volatility     127.00% 130.00%        
Expected life (in years)     4 4        
Stock options activity:                
Options outstanding, beginning balance 1,841 1,682 1,682          
Options granted     201          
Options canceled or forfeited     (33)          
Options outstanding, ending balance     1,841          
Weighted average exercise price, beginning balance $ 2.34 $ 2.34 $ 2.34          
Weighted average exercise price, options granted     $ 3.01          
Weighted average exercise price, options exercised     $ 6.93          
Weighted average exercise price, options cancelled or forfeited     $ 2.57          
Weighted average exercise price, ending balance     $ 2.34          
Weighted average contractual term of options outstanding     3.46       3.76 3.76
Aggregate intrinsic value of options, beginning of period                   
Aggregate intrinsic value of options granted                 
Aggregate intrinsic value of options exercised                 
Aggregate intrinsic value of options cancelled or forfeited                 
Aggregate intrinsic value, end of period                 
Options exercisable     1,146          
Options exercisable, weighted average exercise price     $ 2.11          
Options exercisable, weighted average remaining contractual term (in years)     2.46          
Options exercisable, aggregate intrinsic value     3,890,000          
Options vested and expected to vest     1,886          
Options vested and expected to vest, weighted average exercise price     $ 2.36          
Options vested and expected to vest, weighted average remaining contractual term (in years)     3.25          
Options vested and expected to vest, aggregate intrinsic value     $ 5,725,000          
Weighted average fair value of options granted     $ 3.01